

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.22967706 |
| 2 | protein neddylation (GO:0045116) | 6.74936904 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.74371993 |
| 4 | regulation of platelet aggregation (GO:0090330) | 5.88726507 |
| 5 | low-density lipoprotein particle clearance (GO:0034383) | 5.86819147 |
| 6 | regulation of platelet activation (GO:0010543) | 5.66552588 |
| 7 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.45723176 |
| 8 | platelet aggregation (GO:0070527) | 5.36962891 |
| 9 | blood coagulation, intrinsic pathway (GO:0007597) | 5.30135204 |
| 10 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.96864404 |
| 11 | angiogenesis involved in wound healing (GO:0060055) | 4.84664695 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.82003208 |
| 13 | adenosine receptor signaling pathway (GO:0001973) | 4.80294326 |
| 14 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.79394070 |
| 15 | regulation of sequestering of triglyceride (GO:0010889) | 4.69974528 |
| 16 | negative regulation of platelet activation (GO:0010544) | 4.68377151 |
| 17 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.64205815 |
| 18 | positive regulation of mast cell activation (GO:0033005) | 4.46781245 |
| 19 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.39483359 |
| 20 | fatty acid transmembrane transport (GO:1902001) | 4.38738298 |
| 21 | negative regulation of norepinephrine secretion (GO:0010700) | 4.37497388 |
| 22 | platelet degranulation (GO:0002576) | 4.33977063 |
| 23 | lymph vessel development (GO:0001945) | 4.21229953 |
| 24 | regulation of integrin activation (GO:0033623) | 4.13252962 |
| 25 | neutrophil activation (GO:0042119) | 4.12122794 |
| 26 | lymphangiogenesis (GO:0001946) | 4.02175524 |
| 27 | megakaryocyte development (GO:0035855) | 3.99724172 |
| 28 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.97460117 |
| 29 | glomerular filtration (GO:0003094) | 3.96323012 |
| 30 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.96269488 |
| 31 | lipoxygenase pathway (GO:0019372) | 3.95522040 |
| 32 | regulation of lipoprotein metabolic process (GO:0050746) | 3.95519031 |
| 33 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.94007205 |
| 34 | positive regulation of receptor recycling (GO:0001921) | 3.93162020 |
| 35 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.92711393 |
| 36 | blood vessel maturation (GO:0001955) | 3.88733001 |
| 37 | renal filtration (GO:0097205) | 3.85597236 |
| 38 | surfactant homeostasis (GO:0043129) | 3.85498310 |
| 39 | negative regulation of protein localization to cell surface (GO:2000009) | 3.84828741 |
| 40 | white fat cell differentiation (GO:0050872) | 3.84567411 |
| 41 | negative regulation of heart rate (GO:0010459) | 3.84176979 |
| 42 | brown fat cell differentiation (GO:0050873) | 3.78532434 |
| 43 | protein heterotrimerization (GO:0070208) | 3.74332579 |
| 44 | positive regulation of blood coagulation (GO:0030194) | 3.74323650 |
| 45 | positive regulation of hemostasis (GO:1900048) | 3.74323650 |
| 46 | extracellular fibril organization (GO:0043206) | 3.74296189 |
| 47 | carnitine shuttle (GO:0006853) | 3.72222037 |
| 48 | homotypic cell-cell adhesion (GO:0034109) | 3.71538895 |
| 49 | positive regulation of fatty acid oxidation (GO:0046321) | 3.71213859 |
| 50 | platelet activation (GO:0030168) | 3.69160261 |
| 51 | plasma membrane repair (GO:0001778) | 3.68609876 |
| 52 | triglyceride catabolic process (GO:0019433) | 3.68368629 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.68094536 |
| 54 | low-density lipoprotein particle remodeling (GO:0034374) | 3.67631838 |
| 55 | platelet formation (GO:0030220) | 3.66889043 |
| 56 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.64859342 |
| 57 | regulation of endothelial cell differentiation (GO:0045601) | 3.63610531 |
| 58 | positive regulation of macrophage differentiation (GO:0045651) | 3.61382650 |
| 59 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.59865851 |
| 60 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.58522880 |
| 61 | ovulation from ovarian follicle (GO:0001542) | 3.58341487 |
| 62 | granulocyte activation (GO:0036230) | 3.56783685 |
| 63 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.54315482 |
| 64 | negative regulation of appetite (GO:0032099) | 3.53742000 |
| 65 | negative regulation of response to food (GO:0032096) | 3.53742000 |
| 66 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.50758288 |
| 67 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.50584590 |
| 68 | regulation of cholesterol storage (GO:0010885) | 3.48964825 |
| 69 | endothelial cell morphogenesis (GO:0001886) | 3.46999091 |
| 70 | regulation of tight junction assembly (GO:2000810) | 3.46123038 |
| 71 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.45366037 |
| 72 | lipid particle organization (GO:0034389) | 3.45362165 |
| 73 | apoptotic cell clearance (GO:0043277) | 3.44083617 |
| 74 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.42914920 |
| 75 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.41513496 |
| 76 | valine metabolic process (GO:0006573) | 3.40583057 |
| 77 | axon extension involved in axon guidance (GO:0048846) | 3.39228513 |
| 78 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.39228513 |
| 79 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.36897902 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.36897902 |
| 81 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.35262718 |
| 82 | basement membrane organization (GO:0071711) | 3.34522794 |
| 83 | positive regulation of coagulation (GO:0050820) | 3.34044972 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 3.29897297 |
| 85 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.29090553 |
| 86 | regulation of fatty acid oxidation (GO:0046320) | 3.26886884 |
| 87 | acylglycerol catabolic process (GO:0046464) | 3.25501024 |
| 88 | neutral lipid catabolic process (GO:0046461) | 3.25501024 |
| 89 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.25470943 |
| 90 | fibril organization (GO:0097435) | 3.24148211 |
| 91 | morphogenesis of an endothelium (GO:0003159) | 3.23311933 |
| 92 | endothelial tube morphogenesis (GO:0061154) | 3.23311933 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21324516 |
| 94 | regulation of vasculogenesis (GO:2001212) | 3.15495265 |
| 95 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.13964594 |
| 96 | biotin metabolic process (GO:0006768) | 3.12802618 |
| 97 | purinergic receptor signaling pathway (GO:0035587) | 3.12319391 |
| 98 | cardiac myofibril assembly (GO:0055003) | 3.11964045 |
| 99 | blood vessel endothelial cell migration (GO:0043534) | 3.11272732 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10745339 |
| 101 | negative regulation of T cell apoptotic process (GO:0070233) | 3.08868784 |
| 102 | negative regulation of stress fiber assembly (GO:0051497) | 3.08292648 |
| 103 | regulation of regulatory T cell differentiation (GO:0045589) | 3.08164242 |
| 104 | chondrocyte proliferation (GO:0035988) | 3.08039644 |
| 105 | heart trabecula formation (GO:0060347) | 3.06813967 |
| 106 | negative regulation of heart contraction (GO:0045822) | 3.05972791 |
| 107 | autophagic vacuole fusion (GO:0000046) | 3.05798017 |
| 108 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.05680756 |
| 109 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.03040090 |
| 110 | regulation of mast cell activation (GO:0033003) | 3.02571909 |
| 111 | regulation of hemostasis (GO:1900046) | 3.02407917 |
| 112 | regulation of blood coagulation (GO:0030193) | 3.02407917 |
| 113 | cell adhesion mediated by integrin (GO:0033627) | 3.00773864 |
| 114 | polyamine biosynthetic process (GO:0006596) | 3.00160069 |
| 115 | peptide catabolic process (GO:0043171) | 2.99655653 |
| 116 | membrane raft organization (GO:0031579) | 2.99589589 |
| 117 | phagocytosis, recognition (GO:0006910) | 2.98871992 |
| 118 | regulation of memory T cell differentiation (GO:0043380) | 2.97926649 |
| 119 | beta-amyloid metabolic process (GO:0050435) | 2.96769498 |
| 120 | collagen fibril organization (GO:0030199) | 2.94536908 |
| 121 | positive regulation of macrophage cytokine production (GO:0060907) | 2.93697463 |
| 122 | regulation of receptor recycling (GO:0001919) | 2.90718795 |
| 123 | sarcomere organization (GO:0045214) | 2.89854252 |
| 124 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.89144551 |
| 125 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.88795812 |
| 126 | leukocyte degranulation (GO:0043299) | 2.88585138 |
| 127 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.88330793 |
| 128 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.87275523 |
| 129 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.86211020 |
| 130 | venous blood vessel morphogenesis (GO:0048845) | 2.86154617 |
| 131 | fatty acid oxidation (GO:0019395) | 2.85022979 |
| 132 | positive regulation of vasculogenesis (GO:2001214) | 2.84947469 |
| 133 | chemical homeostasis within a tissue (GO:0048875) | 2.84827193 |
| 134 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.83985099 |
| 135 | regulation of female receptivity (GO:0045924) | 2.83386305 |
| 136 | growth hormone receptor signaling pathway (GO:0060396) | 2.82693305 |
| 137 | termination of signal transduction (GO:0023021) | 2.82175706 |
| 138 | phospholipid homeostasis (GO:0055091) | 2.81560955 |
| 139 | protein localization to endosome (GO:0036010) | 2.80920380 |
| 140 | phagocytosis, engulfment (GO:0006911) | 2.80509960 |
| 141 | negative regulation of interleukin-17 production (GO:0032700) | 2.80200302 |
| 142 | fibroblast migration (GO:0010761) | 2.79759952 |
| 143 | transcytosis (GO:0045056) | 2.79140169 |
| 144 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.79014057 |
| 145 | stress fiber assembly (GO:0043149) | 2.78101406 |
| 146 | tricarboxylic acid cycle (GO:0006099) | 2.77933355 |
| 147 | lipid oxidation (GO:0034440) | 2.77537048 |
| 148 | fatty acid elongation (GO:0030497) | 2.77502991 |
| 149 | protein localization to cell surface (GO:0034394) | 2.76920869 |
| 150 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.76775538 |
| 151 | wound healing, spreading of epidermal cells (GO:0035313) | 2.76335030 |
| 152 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.75934486 |
| 153 | regulation of norepinephrine secretion (GO:0014061) | 2.75923618 |
| 154 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.75031462 |
| 155 | carnitine transmembrane transport (GO:1902603) | 2.74302417 |
| 156 | regulation of coagulation (GO:0050818) | 2.74170617 |
| 157 | glomerular basement membrane development (GO:0032836) | 2.73474245 |
| 158 | cell-substrate junction assembly (GO:0007044) | 2.73260167 |
| 159 | regulation of mast cell degranulation (GO:0043304) | 2.72529493 |
| 160 | cyclooxygenase pathway (GO:0019371) | 2.72473486 |
| 161 | endothelium development (GO:0003158) | 2.72047906 |
| 162 | negative regulation of protein autophosphorylation (GO:0031953) | 2.71609692 |
| 163 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.71343549 |
| 164 | ovulation (GO:0030728) | 2.70376973 |
| 165 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.69816362 |
| 166 | fatty acid catabolic process (GO:0009062) | 2.67319118 |
| 167 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.67295872 |
| 168 | relaxation of smooth muscle (GO:0044557) | 2.67228571 |
| 169 | blood vessel remodeling (GO:0001974) | 2.66375716 |
| 170 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.66341795 |
| 171 | regulation of p38MAPK cascade (GO:1900744) | 2.65714776 |
| 172 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.64839512 |
| 173 | positive regulation of granulocyte differentiation (GO:0030854) | 2.64308599 |
| 174 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.63971239 |
| 175 | positive regulation of mast cell degranulation (GO:0043306) | 2.63971239 |
| 176 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.63171915 |
| 177 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62642359 |
| 178 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.62419260 |
| 179 | high-density lipoprotein particle remodeling (GO:0034375) | 2.60891037 |
| 180 | epithelial cell-cell adhesion (GO:0090136) | 2.60746916 |
| 181 | positive regulation of lipid storage (GO:0010884) | 2.60567420 |
| 182 | epoxygenase P450 pathway (GO:0019373) | 2.57941841 |
| 183 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.57295029 |
| 184 | positive regulation of p38MAPK cascade (GO:1900745) | 2.57235044 |
| 185 | negative regulation of fatty acid transport (GO:2000192) | 2.55134816 |
| 186 | actin-myosin filament sliding (GO:0033275) | 2.52845489 |
| 187 | muscle filament sliding (GO:0030049) | 2.52845489 |
| 188 | endocardial cushion development (GO:0003197) | 2.52495762 |
| 189 | myofibril assembly (GO:0030239) | 2.51878376 |
| 190 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.51373995 |
| 191 | hemidesmosome assembly (GO:0031581) | 2.51150617 |
| 192 | adherens junction assembly (GO:0034333) | 2.49268536 |
| 193 | hippo signaling (GO:0035329) | 2.48903170 |
| 194 | amino-acid betaine transport (GO:0015838) | 2.48509366 |
| 195 | carnitine transport (GO:0015879) | 2.48509366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.20250903 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.73593332 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.52220661 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.31243899 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.99516118 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.99301525 |
| 7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.90163387 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.87997370 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.26281525 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.05685233 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.99815322 |
| 12 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.96692094 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70402639 |
| 14 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.70082669 |
| 15 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.66548687 |
| 16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.48087377 |
| 17 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.44824739 |
| 18 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.44697584 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41362635 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37940648 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.35244122 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.31397237 |
| 23 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.26939250 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22317355 |
| 25 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.21285683 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.18105921 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.16181240 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14461573 |
| 29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.14403145 |
| 30 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.11789440 |
| 31 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.10746183 |
| 32 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.10746183 |
| 33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.07314816 |
| 34 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.07057183 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.03206851 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.99726456 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97794317 |
| 38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.95862611 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.93913421 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93243046 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92250906 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83955005 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83696762 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83532273 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82461559 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.82167222 |
| 47 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.79541413 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78771279 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75470401 |
| 50 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.74257102 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.72833359 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72357557 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72121642 |
| 54 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.71864703 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67950756 |
| 56 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.67747623 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67585997 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65377050 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65041781 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63897289 |
| 61 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.62594936 |
| 62 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61924982 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57341993 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55229989 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54890211 |
| 66 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54222215 |
| 67 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54222215 |
| 68 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.51968679 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50456364 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.49465431 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48176048 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47807920 |
| 73 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.46927633 |
| 74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45169631 |
| 75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45169631 |
| 76 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44191103 |
| 77 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43512106 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42616605 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.42111317 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41747043 |
| 81 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.40462903 |
| 82 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.40444558 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39895669 |
| 84 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.38806997 |
| 85 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.37098648 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35902527 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33508812 |
| 88 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25239700 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23337277 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23144149 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21948138 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21611862 |
| 93 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.20696568 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20419777 |
| 95 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.19319559 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19086694 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17088249 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16678362 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15580408 |
| 100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13779425 |
| 101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13432418 |
| 102 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.13190249 |
| 103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11588427 |
| 104 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.10693004 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09506743 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08918400 |
| 107 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08166953 |
| 108 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07946930 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06589563 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05478458 |
| 111 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05407954 |
| 112 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04796210 |
| 113 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04392655 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02808221 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02002371 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00468963 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00289810 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00064988 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99763196 |
| 120 | MYB_26560356_Chip-Seq_TH2_Human | 0.99285464 |
| 121 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99278188 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99174747 |
| 123 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98125367 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97344524 |
| 125 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.96898102 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96232476 |
| 127 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95750000 |
| 128 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95524320 |
| 129 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95040380 |
| 130 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94471038 |
| 131 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92856399 |
| 132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91953189 |
| 133 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91949732 |
| 134 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91430191 |
| 135 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90965880 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90787871 |
| 137 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89651708 |
| 138 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88615173 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88332146 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87905934 |
| 141 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86951369 |
| 142 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86508759 |
| 143 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86359961 |
| 144 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85453249 |
| 145 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.85019630 |
| 146 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83844491 |
| 147 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.83360240 |
| 148 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.83041226 |
| 149 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.82365290 |
| 150 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81762369 |
| 151 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81279468 |
| 152 | * LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81106451 |
| 153 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80895479 |
| 154 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.80526556 |
| 155 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80472417 |
| 156 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80368939 |
| 157 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80255190 |
| 158 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79971362 |
| 159 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79459311 |
| 160 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.79314627 |
| 161 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.79168354 |
| 162 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.79168354 |
| 163 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78792806 |
| 164 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78726123 |
| 165 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78610720 |
| 166 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.78156944 |
| 167 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.78086589 |
| 168 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77290899 |
| 169 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.76749224 |
| 170 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76505945 |
| 171 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74573830 |
| 172 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74149906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 8.66005112 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.17156403 |
| 3 | MP0005670_abnormal_white_adipose | 3.84409320 |
| 4 | MP0010368_abnormal_lymphatic_system | 3.79097097 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.37151481 |
| 6 | MP0004272_abnormal_basement_membrane | 3.35603563 |
| 7 | MP0005275_abnormal_skin_tensile | 3.31083084 |
| 8 | MP0001879_abnormal_lymphatic_vessel | 3.24989275 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 3.08301986 |
| 10 | MP0004130_abnormal_muscle_cell | 2.99678854 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.77643408 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.76658039 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.67463632 |
| 14 | MP0003303_peritoneal_inflammation | 2.59967482 |
| 15 | MP0001958_emphysema | 2.55955933 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.46384726 |
| 17 | MP0004510_myositis | 2.44679392 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 2.40772348 |
| 19 | MP0003279_aneurysm | 2.37022874 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.35652054 |
| 21 | MP0003828_pulmonary_edema | 2.24027872 |
| 22 | MP0005375_adipose_tissue_phenotype | 2.19033305 |
| 23 | MP0006138_congestive_heart_failure | 2.13567158 |
| 24 | MP0003566_abnormal_cell_adhesion | 2.02198685 |
| 25 | MP0003950_abnormal_plasma_membrane | 2.02148169 |
| 26 | MP0000751_myopathy | 2.00293615 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.90823270 |
| 28 | MP0003724_increased_susceptibility_to | 1.89818483 |
| 29 | MP0005083_abnormal_biliary_tract | 1.88937822 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.82403966 |
| 31 | MP0005330_cardiomyopathy | 1.80453295 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.78675596 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.76741891 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.76099683 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.74782330 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.74726414 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.70308078 |
| 38 | MP0005385_cardiovascular_system_phenoty | 1.70308078 |
| 39 | MP0001851_eye_inflammation | 1.65608917 |
| 40 | MP0006054_spinal_hemorrhage | 1.63501410 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.56930382 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.56174699 |
| 43 | MP0005503_abnormal_tendon_morphology | 1.55524738 |
| 44 | MP0000749_muscle_degeneration | 1.53825874 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.53233514 |
| 46 | MP0002132_abnormal_respiratory_system | 1.52944996 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.52410522 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.51796028 |
| 49 | MP0000343_altered_response_to | 1.49388437 |
| 50 | MP0003638_abnormal_response/metabolism_ | 1.48399697 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.48192974 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.47618449 |
| 53 | MP0002295_abnormal_pulmonary_circulatio | 1.46573496 |
| 54 | MP0003091_abnormal_cell_migration | 1.46493263 |
| 55 | MP0002971_abnormal_brown_adipose | 1.44818096 |
| 56 | MP0005620_abnormal_muscle_contractility | 1.44210141 |
| 57 | MP0000767_abnormal_smooth_muscle | 1.43307464 |
| 58 | MP0010630_abnormal_cardiac_muscle | 1.42573828 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.42170051 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.42170051 |
| 61 | MP0005671_abnormal_response_to | 1.38805791 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.38297789 |
| 63 | MP0003436_decreased_susceptibility_to | 1.36905871 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.36819597 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.36037078 |
| 66 | MP0005410_abnormal_fertilization | 1.33118794 |
| 67 | MP0002736_abnormal_nociception_after | 1.32674655 |
| 68 | MP0008872_abnormal_physiological_respon | 1.30936446 |
| 69 | MP0002398_abnormal_bone_marrow | 1.30452628 |
| 70 | MP0004484_altered_response_of | 1.30242619 |
| 71 | MP0009115_abnormal_fat_cell | 1.29395028 |
| 72 | MP0001663_abnormal_digestive_system | 1.28765331 |
| 73 | MP0000858_altered_metastatic_potential | 1.25721435 |
| 74 | MP0002723_abnormal_immune_serum | 1.20203074 |
| 75 | MP0009763_increased_sensitivity_to | 1.19291924 |
| 76 | MP0003045_fibrosis | 1.19021225 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.18793821 |
| 78 | MP0005595_abnormal_vascular_smooth | 1.17883074 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 1.13617134 |
| 80 | MP0001800_abnormal_humoral_immune | 1.13043125 |
| 81 | MP0004947_skin_inflammation | 1.13007064 |
| 82 | MP0010329_abnormal_lipoprotein_level | 1.12594805 |
| 83 | MP0002452_abnormal_antigen_presenting | 1.11808584 |
| 84 | MP0002128_abnormal_blood_circulation | 1.11705890 |
| 85 | MP0002060_abnormal_skin_morphology | 1.10970192 |
| 86 | MP0000759_abnormal_skeletal_muscle | 1.09998495 |
| 87 | MP0002419_abnormal_innate_immunity | 1.09713159 |
| 88 | MP0000733_abnormal_muscle_development | 1.07981812 |
| 89 | MP0005388_respiratory_system_phenotype | 1.06768715 |
| 90 | MP0002133_abnormal_respiratory_system | 1.06768715 |
| 91 | MP0005164_abnormal_response_to | 1.06538636 |
| 92 | MP0009764_decreased_sensitivity_to | 1.05692596 |
| 93 | MP0000249_abnormal_blood_vessel | 1.04542104 |
| 94 | MP0005023_abnormal_wound_healing | 1.02858391 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 1.02668756 |
| 96 | MP0005334_abnormal_fat_pad | 1.00764719 |
| 97 | MP0002420_abnormal_adaptive_immunity | 1.00346550 |
| 98 | MP0003879_abnormal_hair_cell | 0.99043856 |
| 99 | MP0001819_abnormal_immune_cell | 0.98698362 |
| 100 | MP0002108_abnormal_muscle_morphology | 0.98489717 |
| 101 | MP0005165_increased_susceptibility_to | 0.97126828 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.97002820 |
| 103 | MP0003075_altered_response_to | 0.96313639 |
| 104 | MP0003866_abnormal_defecation | 0.95982088 |
| 105 | MP0002429_abnormal_blood_cell | 0.94847769 |
| 106 | MP0005025_abnormal_response_to | 0.94529755 |
| 107 | MP0005409_darkened_coat_color | 0.94364011 |
| 108 | MP0008874_decreased_physiological_sensi | 0.94126175 |
| 109 | MP0001614_abnormal_blood_vessel | 0.93794070 |
| 110 | MP0001664_abnormal_digestion | 0.93123023 |
| 111 | MP0002733_abnormal_thermal_nociception | 0.92215333 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.90662841 |
| 113 | MP0005387_immune_system_phenotype | 0.90404409 |
| 114 | MP0001790_abnormal_immune_system | 0.90404409 |
| 115 | MP0004147_increased_porphyrin_level | 0.89605783 |
| 116 | MP0002106_abnormal_muscle_physiology | 0.89016220 |
| 117 | MP0010352_gastrointestinal_tract_polyps | 0.88694494 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.88281409 |
| 119 | MP0002168_other_aberrant_phenotype | 0.88199431 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.87501947 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.85771890 |
| 122 | MP0003959_abnormal_lean_body | 0.85369298 |
| 123 | MP0002925_abnormal_cardiovascular_devel | 0.84615785 |
| 124 | MP0005369_muscle_phenotype | 0.83304199 |
| 125 | MP0008004_abnormal_stomach_pH | 0.83236648 |
| 126 | MP0000716_abnormal_immune_system | 0.83220770 |
| 127 | MP0002722_abnormal_immune_system | 0.83124611 |
| 128 | MP0003300_gastrointestinal_ulcer | 0.82702023 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.82096408 |
| 130 | MP0000266_abnormal_heart_morphology | 0.81934253 |
| 131 | MP0002970_abnormal_white_adipose | 0.80705080 |
| 132 | MP0001661_extended_life_span | 0.80596528 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.80300923 |
| 134 | MP0000685_abnormal_immune_system | 0.79743501 |
| 135 | MP0004883_abnormal_blood_vessel | 0.78187084 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.77981775 |
| 137 | MP0004085_abnormal_heartbeat | 0.77705484 |
| 138 | MP0009333_abnormal_splenocyte_physiolog | 0.77030840 |
| 139 | MP0003806_abnormal_nucleotide_metabolis | 0.76193804 |
| 140 | MP0005508_abnormal_skeleton_morphology | 0.75770359 |
| 141 | MP0009379_abnormal_foot_pigmentation | 0.74965423 |
| 142 | MP0009697_abnormal_copulation | 0.74860870 |
| 143 | MP0005535_abnormal_body_temperature | 0.74586002 |
| 144 | MP0001968_abnormal_touch/_nociception | 0.74429879 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.73714226 |
| 146 | MP0002877_abnormal_melanocyte_morpholog | 0.73524982 |
| 147 | MP0006276_abnormal_autonomic_nervous | 0.72887500 |
| 148 | MP0000015_abnormal_ear_pigmentation | 0.72115738 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.71703237 |
| 150 | MP0006036_abnormal_mitochondrial_physio | 0.70809107 |
| 151 | MP0003646_muscle_fatigue | 0.70063093 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.69512431 |
| 153 | MP0001542_abnormal_bone_strength | 0.68239543 |
| 154 | MP0001175_abnormal_lung_morphology | 0.65529318 |
| 155 | MP0003137_abnormal_impulse_conducting | 0.65082522 |
| 156 | MP0002166_altered_tumor_susceptibility | 0.64899262 |
| 157 | MP0000747_muscle_weakness | 0.63341659 |
| 158 | MP0002269_muscular_atrophy | 0.62921256 |
| 159 | MP0003567_abnormal_fetal_cardiomyocyte | 0.62169244 |
| 160 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60966888 |
| 161 | MP0002127_abnormal_cardiovascular_syste | 0.60275468 |
| 162 | MP0002138_abnormal_hepatobiliary_system | 0.58790268 |
| 163 | MP0001177_atelectasis | 0.57524685 |
| 164 | MP0001881_abnormal_mammary_gland | 0.55570671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal platelet volume (HP:0011876) | 9.57534454 |
| 2 | Petechiae (HP:0000967) | 8.92020249 |
| 3 | Purpura (HP:0000979) | 8.25379403 |
| 4 | Epistaxis (HP:0000421) | 7.64114508 |
| 5 | Gingival bleeding (HP:0000225) | 6.55990667 |
| 6 | Abnormal platelet function (HP:0011869) | 5.76927904 |
| 7 | Impaired platelet aggregation (HP:0003540) | 5.76927904 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.72228028 |
| 9 | Premature rupture of membranes (HP:0001788) | 5.06910958 |
| 10 | Protrusio acetabuli (HP:0003179) | 4.74578824 |
| 11 | Increased connective tissue (HP:0009025) | 4.61096784 |
| 12 | Broad metatarsal (HP:0001783) | 4.21924573 |
| 13 | Cerebral aneurysm (HP:0004944) | 4.12009684 |
| 14 | Poikilocytosis (HP:0004447) | 3.97280865 |
| 15 | Muscle fiber splitting (HP:0003555) | 3.93043021 |
| 16 | Dyschromatopsia (HP:0007641) | 3.82458111 |
| 17 | Acanthosis nigricans (HP:0000956) | 3.79927081 |
| 18 | Conjunctival telangiectasia (HP:0000524) | 3.79876343 |
| 19 | Acanthocytosis (HP:0001927) | 3.78583690 |
| 20 | Aortic dissection (HP:0002647) | 3.77360051 |
| 21 | Aortic aneurysm (HP:0004942) | 3.72896616 |
| 22 | Spinal rigidity (HP:0003306) | 3.72525735 |
| 23 | Ankle contracture (HP:0006466) | 3.64681986 |
| 24 | Hematochezia (HP:0002573) | 3.63140724 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 3.47960300 |
| 26 | Bruising susceptibility (HP:0000978) | 3.46158803 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.45778456 |
| 28 | Type 1 muscle fiber predominance (HP:0003803) | 3.42523811 |
| 29 | Lipoatrophy (HP:0100578) | 3.37670437 |
| 30 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.35381592 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.34618297 |
| 32 | Polycythemia (HP:0001901) | 3.34060448 |
| 33 | Hyporeflexia of lower limbs (HP:0002600) | 3.33788117 |
| 34 | Difficulty running (HP:0009046) | 3.22773179 |
| 35 | Sudden death (HP:0001699) | 3.19738407 |
| 36 | Abnormal pupillary function (HP:0007686) | 3.19560001 |
| 37 | Shallow orbits (HP:0000586) | 3.17632070 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.16787574 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.12066012 |
| 40 | Oligomenorrhea (HP:0000876) | 3.02084101 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.98133786 |
| 42 | Joint hemorrhage (HP:0005261) | 2.96875244 |
| 43 | Atrial fibrillation (HP:0005110) | 2.96123036 |
| 44 | Atrophic scars (HP:0001075) | 2.91241636 |
| 45 | Paralysis (HP:0003470) | 2.84757126 |
| 46 | Myoglobinuria (HP:0002913) | 2.83462446 |
| 47 | Hypertriglyceridemia (HP:0002155) | 2.78047925 |
| 48 | Aneurysm (HP:0002617) | 2.75886552 |
| 49 | Primary atrial arrhythmia (HP:0001692) | 2.70413176 |
| 50 | Supraventricular arrhythmia (HP:0005115) | 2.69278809 |
| 51 | Hepatosplenomegaly (HP:0001433) | 2.68762271 |
| 52 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.62919120 |
| 53 | Dilatation of the ascending aorta (HP:0005111) | 2.61808740 |
| 54 | Increased density of long bones (HP:0006392) | 2.59751801 |
| 55 | Mitral valve prolapse (HP:0001634) | 2.59648309 |
| 56 | Lymphangioma (HP:0100764) | 2.58920408 |
| 57 | Difficulty climbing stairs (HP:0003551) | 2.58840156 |
| 58 | Supraventricular tachycardia (HP:0004755) | 2.55599651 |
| 59 | Joint swelling (HP:0001386) | 2.53770518 |
| 60 | Stomatitis (HP:0010280) | 2.53750246 |
| 61 | Decreased central vision (HP:0007663) | 2.49487211 |
| 62 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.49101205 |
| 63 | Peritonitis (HP:0002586) | 2.48494566 |
| 64 | Soft skin (HP:0000977) | 2.48357944 |
| 65 | Scapular winging (HP:0003691) | 2.45616097 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.44935953 |
| 67 | Fragile skin (HP:0001030) | 2.42400629 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41650756 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.41650756 |
| 70 | Xanthomatosis (HP:0000991) | 2.40418764 |
| 71 | Dilated cardiomyopathy (HP:0001644) | 2.37981381 |
| 72 | Abnormality of lateral ventricle (HP:0030047) | 2.37807476 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.37529107 |
| 74 | Tinnitus (HP:0000360) | 2.33996811 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.32595493 |
| 76 | Venous abnormality (HP:0002624) | 2.31961236 |
| 77 | Growth hormone excess (HP:0000845) | 2.28601070 |
| 78 | Bladder diverticulum (HP:0000015) | 2.26727311 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.26042541 |
| 80 | Rhabdomyolysis (HP:0003201) | 2.25203984 |
| 81 | Myotonia (HP:0002486) | 2.24758371 |
| 82 | Arterial thrombosis (HP:0004420) | 2.24407230 |
| 83 | Exercise-induced muscle cramps (HP:0003710) | 2.24364602 |
| 84 | Exercise-induced myalgia (HP:0003738) | 2.24131513 |
| 85 | Follicular hyperkeratosis (HP:0007502) | 2.22991515 |
| 86 | Abnormality of the calf musculature (HP:0001430) | 2.22823617 |
| 87 | Increased IgM level (HP:0003496) | 2.22772328 |
| 88 | Abnormal auditory evoked potentials (HP:0006958) | 2.22582363 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 2.21107675 |
| 90 | Visceral angiomatosis (HP:0100761) | 2.20679993 |
| 91 | Hypoalphalipoproteinemia (HP:0003233) | 2.18109297 |
| 92 | Bone cyst (HP:0012062) | 2.16732444 |
| 93 | Long toe (HP:0010511) | 2.16703349 |
| 94 | Cervical subluxation (HP:0003308) | 2.16664364 |
| 95 | Facial diplegia (HP:0001349) | 2.11512916 |
| 96 | Ventricular fibrillation (HP:0001663) | 2.11499185 |
| 97 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10299755 |
| 98 | Increased mean platelet volume (HP:0011877) | 2.10235026 |
| 99 | Vascular tortuosity (HP:0004948) | 2.09949176 |
| 100 | Hypoglycemic coma (HP:0001325) | 2.09691571 |
| 101 | Rectal prolapse (HP:0002035) | 2.08935456 |
| 102 | Camptodactyly of toe (HP:0001836) | 2.08499939 |
| 103 | Insulin resistance (HP:0000855) | 2.08025606 |
| 104 | Hemangiomatosis (HP:0007461) | 2.06084398 |
| 105 | Spontaneous abortion (HP:0005268) | 2.05150461 |
| 106 | Blue sclerae (HP:0000592) | 2.05059224 |
| 107 | Esophageal varix (HP:0002040) | 2.04009951 |
| 108 | EMG: myopathic abnormalities (HP:0003458) | 2.02296804 |
| 109 | Cerebral hemorrhage (HP:0001342) | 2.02079287 |
| 110 | Venous insufficiency (HP:0005293) | 2.00696491 |
| 111 | Wrist flexion contracture (HP:0001239) | 2.00463779 |
| 112 | Prolonged bleeding time (HP:0003010) | 11.3124825 |
| 113 | Menorrhagia (HP:0000132) | 10.2357902 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98991562 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 1.97262713 |
| 116 | Wormian bones (HP:0002645) | 1.96962985 |
| 117 | Upper limb muscle weakness (HP:0003484) | 1.95366855 |
| 118 | Obstructive lung disease (HP:0006536) | 1.94581197 |
| 119 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94581197 |
| 120 | Asymmetric septal hypertrophy (HP:0001670) | 1.93954447 |
| 121 | Round ear (HP:0100830) | 1.93438986 |
| 122 | Deep venous thrombosis (HP:0002625) | 1.93086756 |
| 123 | Short nail (HP:0001799) | 1.92379599 |
| 124 | Encephalitis (HP:0002383) | 1.91695522 |
| 125 | Muscle stiffness (HP:0003552) | 1.91546431 |
| 126 | Buphthalmos (HP:0000557) | 1.91348737 |
| 127 | Calf muscle hypertrophy (HP:0008981) | 1.90785239 |
| 128 | Episodic fever (HP:0001954) | 1.90176386 |
| 129 | Palpitations (HP:0001962) | 1.88464032 |
| 130 | Eczematoid dermatitis (HP:0000976) | 1.87581983 |
| 131 | Autoimmune hemolytic anemia (HP:0001890) | 1.87369594 |
| 132 | Generalized aminoaciduria (HP:0002909) | 1.86356530 |
| 133 | Increased serum ferritin (HP:0003281) | 1.86323381 |
| 134 | Prolonged QT interval (HP:0001657) | 1.85165096 |
| 135 | Myocardial infarction (HP:0001658) | 1.85064558 |
| 136 | Vertigo (HP:0002321) | 1.84398600 |
| 137 | Hyperglycinuria (HP:0003108) | 1.84224936 |
| 138 | Hyperthyroidism (HP:0000836) | 1.84045048 |
| 139 | Nausea (HP:0002018) | 1.83541326 |
| 140 | Mucosal telangiectasiae (HP:0100579) | 1.82947435 |
| 141 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.82856791 |
| 142 | Abnormal cartilage morphology (HP:0002763) | 1.82678128 |
| 143 | Subaortic stenosis (HP:0001682) | 1.81035670 |
| 144 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.81035670 |
| 145 | Papillary thyroid carcinoma (HP:0002895) | 1.80625059 |
| 146 | Cavernous hemangioma (HP:0001048) | 1.80205685 |
| 147 | Chest pain (HP:0100749) | 1.80133606 |
| 148 | Hemorrhage of the eye (HP:0011885) | 1.79627769 |
| 149 | Male infertility (HP:0003251) | 1.78758513 |
| 150 | Nonimmune hydrops fetalis (HP:0001790) | 1.78539143 |
| 151 | Abnormality of dentin (HP:0010299) | 1.78116229 |
| 152 | Arterial tortuosity (HP:0005116) | 1.74814426 |
| 153 | Thyroid-stimulating hormone excess (HP:0002925) | 1.73531559 |
| 154 | Distal lower limb amyotrophy (HP:0008944) | 1.73379855 |
| 155 | Ketoacidosis (HP:0001993) | 1.73154658 |
| 156 | Mitral stenosis (HP:0001718) | 1.67905669 |
| 157 | Abnormality of the prostate (HP:0008775) | 1.66963162 |
| 158 | Thrombocytosis (HP:0001894) | 1.65940427 |
| 159 | Biliary tract neoplasm (HP:0100574) | 1.65842067 |
| 160 | Thrombophlebitis (HP:0004418) | 1.61532125 |
| 161 | Central scotoma (HP:0000603) | 1.61110497 |
| 162 | Dysautonomia (HP:0002459) | 1.59501006 |
| 163 | Muscle fibrillation (HP:0010546) | 1.59056180 |
| 164 | Basal ganglia calcification (HP:0002135) | 1.57579464 |
| 165 | Hypophosphatemic rickets (HP:0004912) | 1.57496775 |
| 166 | 3-Methylglutaconic aciduria (HP:0003535) | 1.54603780 |
| 167 | Recurrent abscess formation (HP:0002722) | 1.51803453 |
| 168 | Tongue fasciculations (HP:0001308) | 1.48522235 |
| 169 | Cerebral ischemia (HP:0002637) | 1.43757117 |
| 170 | Dysostosis multiplex (HP:0000943) | 1.42607257 |
| 171 | Portal hypertension (HP:0001409) | 1.41428170 |
| 172 | Testicular neoplasm (HP:0010788) | 1.41062536 |
| 173 | Bundle branch block (HP:0011710) | 1.40851825 |
| 174 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.39811632 |
| 175 | Type 2 muscle fiber atrophy (HP:0003554) | 1.39181636 |
| 176 | Pulmonary embolism (HP:0002204) | 1.39173175 |
| 177 | Muscle fiber atrophy (HP:0100295) | 1.39145920 |
| 178 | Leukocytosis (HP:0001974) | 1.37691646 |
| 179 | Hypoplasia of the fovea (HP:0007750) | 1.37117602 |
| 180 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.37117602 |
| 181 | Visual hallucinations (HP:0002367) | 1.36707297 |
| 182 | Weak cry (HP:0001612) | 1.36405768 |
| 183 | Distal lower limb muscle weakness (HP:0009053) | 1.36093659 |
| 184 | Abnormality of the right ventricle (HP:0001707) | 1.35169084 |
| 185 | Recurrent bacterial skin infections (HP:0005406) | 1.33943486 |
| 186 | Arthropathy (HP:0003040) | 1.33042301 |
| 187 | Amaurosis fugax (HP:0100576) | 1.32996079 |
| 188 | Diplopia (HP:0000651) | 1.32960587 |
| 189 | Abnormality of binocular vision (HP:0011514) | 1.32960587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.12524035 |
| 2 | TIE1 | 6.07533200 |
| 3 | TRIB3 | 4.02797673 |
| 4 | MST4 | 4.02364061 |
| 5 | TTN | 3.59354850 |
| 6 | TEC | 3.34913728 |
| 7 | BTK | 3.05364011 |
| 8 | KDR | 2.99659534 |
| 9 | TGFBR2 | 2.99643446 |
| 10 | RIPK1 | 2.59741738 |
| 11 | MYLK | 2.52357979 |
| 12 | BMPR2 | 2.48757138 |
| 13 | TAOK3 | 2.48368535 |
| 14 | EIF2AK1 | 2.45528358 |
| 15 | CAMK1D | 2.44447410 |
| 16 | SYK | 2.26122973 |
| 17 | PKN2 | 2.15148229 |
| 18 | GRK5 | 2.14970294 |
| 19 | PDGFRA | 2.14608615 |
| 20 | SIK1 | 2.12273208 |
| 21 | ZAP70 | 2.10405808 |
| 22 | CSF1R | 2.08886982 |
| 23 | EPHB2 | 1.94273249 |
| 24 | LATS1 | 1.90822445 |
| 25 | BCKDK | 1.86338049 |
| 26 | DDR2 | 1.84379345 |
| 27 | PDK4 | 1.79910942 |
| 28 | PDK3 | 1.79910942 |
| 29 | PDK2 | 1.76628387 |
| 30 | LMTK2 | 1.74307326 |
| 31 | DMPK | 1.73061891 |
| 32 | ERN1 | 1.72257166 |
| 33 | FES | 1.71754014 |
| 34 | GRK6 | 1.65882442 |
| 35 | TGFBR1 | 1.61107415 |
| 36 | PTK2B | 1.58117703 |
| 37 | CAMK1G | 1.56647811 |
| 38 | PIK3CA | 1.51594431 |
| 39 | FER | 1.50465126 |
| 40 | HCK | 1.48918862 |
| 41 | BLK | 1.44487733 |
| 42 | FGR | 1.44417152 |
| 43 | TRPM7 | 1.39885354 |
| 44 | LRRK2 | 1.34294179 |
| 45 | PAK2 | 1.29004491 |
| 46 | FGFR2 | 1.25624270 |
| 47 | LATS2 | 1.23175414 |
| 48 | ILK | 1.23061639 |
| 49 | ITK | 1.20486795 |
| 50 | PTK6 | 1.15182751 |
| 51 | FGFR4 | 1.09659644 |
| 52 | PHKG1 | 1.07983592 |
| 53 | PHKG2 | 1.07983592 |
| 54 | EPHB1 | 1.07689233 |
| 55 | MAP2K3 | 1.06664752 |
| 56 | LYN | 1.05835122 |
| 57 | FRK | 1.05224438 |
| 58 | PRKD1 | 1.04626023 |
| 59 | MET | 1.03581484 |
| 60 | PAK1 | 1.03068151 |
| 61 | NEK9 | 1.02745021 |
| 62 | OBSCN | 1.00306179 |
| 63 | MAP3K3 | 0.98484853 |
| 64 | MST1R | 0.98088673 |
| 65 | FGFR3 | 0.97351245 |
| 66 | PLK2 | 0.95864853 |
| 67 | ADRBK2 | 0.95227121 |
| 68 | TXK | 0.94899435 |
| 69 | PRKAA2 | 0.94041149 |
| 70 | PTK2 | 0.93602829 |
| 71 | MARK3 | 0.93476690 |
| 72 | PAK4 | 0.92844149 |
| 73 | SIK3 | 0.90766104 |
| 74 | IRAK1 | 0.90739160 |
| 75 | TNK2 | 0.90084261 |
| 76 | PDGFRB | 0.89349819 |
| 77 | IKBKB | 0.89337123 |
| 78 | PAK3 | 0.87506861 |
| 79 | DAPK2 | 0.86891760 |
| 80 | PRKG2 | 0.86373811 |
| 81 | ACVR1B | 0.84256397 |
| 82 | INSRR | 0.83746600 |
| 83 | MAP3K5 | 0.83535527 |
| 84 | ERBB2 | 0.81628769 |
| 85 | ROCK1 | 0.81328463 |
| 86 | MAP2K1 | 0.81279419 |
| 87 | ADRBK1 | 0.80883849 |
| 88 | MATK | 0.78237145 |
| 89 | PRKCH | 0.75245526 |
| 90 | PDK1 | 0.71023542 |
| 91 | BMX | 0.70789499 |
| 92 | TLK1 | 0.69911741 |
| 93 | STK3 | 0.68696050 |
| 94 | JAK1 | 0.67970859 |
| 95 | MOS | 0.63848550 |
| 96 | PRKD3 | 0.63161252 |
| 97 | EEF2K | 0.60473716 |
| 98 | CSK | 0.59857644 |
| 99 | PIM2 | 0.58739138 |
| 100 | GRK1 | 0.58412231 |
| 101 | FGFR1 | 0.58048777 |
| 102 | PRKD2 | 0.57938882 |
| 103 | MTOR | 0.57646825 |
| 104 | LCK | 0.57319080 |
| 105 | RET | 0.55929892 |
| 106 | MUSK | 0.55489854 |
| 107 | CDK6 | 0.55039733 |
| 108 | EPHA3 | 0.53998881 |
| 109 | PRKACG | 0.53209252 |
| 110 | PDPK1 | 0.53201315 |
| 111 | IGF1R | 0.51945430 |
| 112 | STK4 | 0.51167251 |
| 113 | LIMK1 | 0.51090682 |
| 114 | MAPK12 | 0.50113094 |
| 115 | CAMKK2 | 0.48452264 |
| 116 | GSK3A | 0.48209765 |
| 117 | MAP3K11 | 0.47508090 |
| 118 | FYN | 0.47459859 |
| 119 | INSR | 0.46178396 |
| 120 | TAOK2 | 0.45971478 |
| 121 | WNK1 | 0.45915784 |
| 122 | PIK3CG | 0.44382951 |
| 123 | MAPKAPK3 | 0.44354725 |
| 124 | STK10 | 0.44110039 |
| 125 | CDK9 | 0.42948858 |
| 126 | MAP3K12 | 0.42900466 |
| 127 | PKN1 | 0.41964100 |
| 128 | MAP4K1 | 0.41670246 |
| 129 | ROCK2 | 0.41498661 |
| 130 | MAP3K1 | 0.40174688 |
| 131 | TESK1 | 0.39778859 |
| 132 | FLT3 | 0.39503166 |
| 133 | SRC | 0.38590091 |
| 134 | TNIK | 0.38056016 |
| 135 | STK24 | 0.37975308 |
| 136 | PRKG1 | 0.37771202 |
| 137 | DAPK3 | 0.37161132 |
| 138 | SGK2 | 0.36942435 |
| 139 | DAPK1 | 0.36007940 |
| 140 | BMPR1B | 0.34169458 |
| 141 | NUAK1 | 0.33280112 |
| 142 | PRKCQ | 0.32000985 |
| 143 | PRKAA1 | 0.31639821 |
| 144 | MAP3K7 | 0.31240104 |
| 145 | PRKCD | 0.30499376 |
| 146 | MAP3K6 | 0.30240037 |
| 147 | NLK | 0.29772856 |
| 148 | JAK3 | 0.28370208 |
| 149 | HIPK2 | 0.27325620 |
| 150 | YES1 | 0.27039625 |
| 151 | ZAK | 0.25998368 |
| 152 | STK38L | 0.25782910 |
| 153 | ABL2 | 0.25172393 |
| 154 | PRKCB | 0.24683065 |
| 155 | PRKCE | 0.24646810 |
| 156 | SGK3 | 0.23875210 |
| 157 | MARK2 | 0.23541751 |
| 158 | CAMK1 | 0.22914453 |
| 159 | EGFR | 0.22894075 |
| 160 | JAK2 | 0.22550462 |
| 161 | CDC42BPA | 0.22479067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.60704076 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22856977 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.13150000 |
| 4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.05513128 |
| 5 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.87209006 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.77037488 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.73027473 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60910483 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.58524752 |
| 10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.50704922 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.47518210 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.38782394 |
| 13 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.31998564 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.30698560 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 2.29612703 |
| 16 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.17428166 |
| 17 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.11886261 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.97439313 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.76263410 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.74233894 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.73363608 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72856529 |
| 23 | Adherens junction_Homo sapiens_hsa04520 | 1.71001668 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50356572 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47134980 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.45222477 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44865940 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38554286 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36922240 |
| 30 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.36341241 |
| 31 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.36074097 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30670278 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.26697733 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25629979 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25158277 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.24689960 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.24547631 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22366854 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20369146 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.14447158 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14427797 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14361095 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12369210 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11813591 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11629490 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 1.11183364 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09206008 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08213644 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.07941665 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07232851 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.06597682 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06458760 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.02909465 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98688308 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.96186948 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95727007 |
| 57 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.94905721 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.94630913 |
| 59 | Alcoholism_Homo sapiens_hsa05034 | 0.92286809 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92206131 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91879843 |
| 62 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90448345 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90436310 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90085383 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88319130 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87458962 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87085647 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86430067 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85724707 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83542051 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83483911 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81261030 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79513722 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.79398644 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76838224 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.76561021 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76499173 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76390431 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76235031 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75303693 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71913657 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71849835 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.70766171 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70569870 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70172715 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.69952583 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69767977 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69703054 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69337965 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68433847 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68371993 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67458171 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66583230 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66208269 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65701077 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65599738 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64708375 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64589890 |
| 99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64346401 |
| 100 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62773254 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62424696 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62353259 |
| 103 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61335409 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60588638 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60408591 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57138587 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.56906054 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56677093 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.55648456 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55317638 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54332025 |
| 112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53002286 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52315860 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52181220 |
| 115 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51603494 |
| 116 | Melanoma_Homo sapiens_hsa05218 | 0.50698935 |
| 117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50123969 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49608690 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48923690 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.48680084 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48030776 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47894802 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47857540 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47482754 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.46566111 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45664994 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45143494 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.45067129 |
| 129 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44893063 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.44046794 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43986372 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43837401 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43596782 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43418349 |
| 135 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43205575 |
| 136 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43094036 |
| 137 | Salmonella infection_Homo sapiens_hsa05132 | 0.43006611 |
| 138 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42854714 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42113143 |
| 140 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41681228 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.41618149 |
| 142 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38385502 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.38295145 |
| 144 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38272347 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37603284 |
| 146 | Axon guidance_Homo sapiens_hsa04360 | 0.35870028 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34593302 |
| 148 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33628035 |
| 149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32336430 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.31925846 |
| 151 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31415833 |
| 152 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30726630 |
| 153 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.29791782 |
| 154 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28300834 |
| 155 | Gap junction_Homo sapiens_hsa04540 | 0.28291446 |
| 156 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27534837 |
| 157 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.26137976 |
| 158 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25417531 |
| 159 | ABC transporters_Homo sapiens_hsa02010 | 0.25009811 |
| 160 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24749492 |
| 161 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23703552 |

